Genetic products differentially expressed in tumors and use thereof

Details for Australian Patent Application No. 2003219045 (hide)

Owner Ganymed Pharmaceuticals AG

Inventors Tureci, Ozlem; Sahin, Ugur; Koslowski, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003219045

PCT Number PCT/EP03/02556

PCT Pub. Number WO2003/076631

Priority 102 11 088.3 13.03.02 DE

Filing date 12 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 18 September 2008

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 102 11 088.3 13.03.02 DE

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003219045

18 September 2008 Application Accepted

  Published as AU-B-2003219045

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219046-CATIONIC POLYMERS AND THE USE THEREOF IN COSMETIC FORMULATIONS

2003219044-SWITCHING CIRCUIT FOR PRODUCING AN ADJUSTABLE OUTPUT CHARACTERISTIC